Cargando…
Increase in Serum Interleukin-1 Receptor Antagonist (IL-1ra) Levels after Wheelchair Half Marathon Race in Male Athletes with Spinal Cord Injury
Exercise increases the serum level of interleukin-6 (IL-6), which in turn stimulates the production of various inflammatory cytokine antagonists, such as interleukin-1 receptor antagonist (IL-1ra). Individuals with cervical spinal cord injury (CSCI) are at high risk of inflammatory conditions. This...
Autores principales: | Nakahama-Matsushima, Masumi, Kamijyo, Yoshi-ichiro, Umemoto, Yasunori, Hashizaki, Takamasa, Nishimura, Yukihide, Furusawa, Kazunari, Furotani, Yohei, Tajima, Fumihiro, Kouda, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672277/ https://www.ncbi.nlm.nih.gov/pubmed/38002710 http://dx.doi.org/10.3390/jcm12227098 |
Ejemplares similares
-
Follow-Up Study of Subdermal Low-Echoic Lesions in the Ischial Region in Wheelchair Users With Spinal Cord Injuries
por: Kawasaki, Shinji, et al.
Publicado: (2022) -
Surface electromyographic activity of the erector spinae and multifidus during arm- and leg-ergometer exercises in young healthy men
por: Shima, Daichi, et al.
Publicado: (2022) -
Effects of continuous bicycle ergometer and step exercises from admission to discharge in a patient with myelodysplastic syndrome undergoing myeloablative conditioning and hematopoietic stem cell transplantation: A case report
por: Kawanishi, Makoto, et al.
Publicado: (2023) -
Effectiveness of a 3-Week Rehabilitation Program Combining Muscle Strengthening and Endurance Exercises Prior to Total Knee Arthroplasty: A Non-Randomized Controlled Trial
por: Hashizaki, Takamasa, et al.
Publicado: (2023) -
Case report: Rehabilitation course in thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly syndrome complicated by cerebral infarction in the left parabolic coronary region
por: Hashizaki, Takamasa, et al.
Publicado: (2023)